Search - tctmd.com

Displaying 81 - 100 of 1259

Sort: Relevancy | Date

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

News Conference News ACC 2024

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

Yael L. Maxwell

April 07, 2024

News Daily News

DCB in STEMI Match DES Through 5 Years: REVELATION

Caitlin E. Cox

March 27, 2024

News Conference News CRT 2024

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

L.A. McKeown

March 15, 2024

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

Presentation Miami Valves 2024

Flaring of protruding ostial coronary stents prior to TAVR

Presenter: Jonathan X. Fang

February 03, 2024

News Daily News

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Michael O'Riordan

January 09, 2024

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Daily News

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Michael O'Riordan

November 24, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News TCT 2023

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Michael O'Riordan

November 01, 2023

Presentation TCT 2023

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Presenter: Roxana Mehran

October 26, 2023

Presentation TCT 2023

Dedicated Bifurcation Stents: Why Did They Disappear, and What’s on the Horizon?

Presenter: Ricardo Costa

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

Presenter: Hyun Jin Ahn

October 25, 2023

Presentation TCT 2023

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Presenter: Azfar Zaman

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: Usman Naseer

October 25, 2023

Advertisement

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

ULTIMATE-DAPT: Another Boost for Solo Ticagrelor 1 Month After ACS PCI

DCB in STEMI Match DES Through 5 Years: REVELATION

SAFE-MCS: Monitoring System Intercepts Bleeding in High-risk PCI

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Flaring of protruding ostial coronary stents prior to TAVR

TLR Rates Rise Steadily After Left Main PCI, but Deaths Stay Stable

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

PCI With Intravascular Imaging or Functional Testing Bests Angiography Alone

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Ultrathin Stent Holds Its Own in High-Bleeding-Risk Patients: COMPARE 60/80

Global Epidemic of Diabetes and the unmet need for Novel Stents for PCI

Dedicated Bifurcation Stents: Why Did They Disappear, and What’s on the Horizon?

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

TCT 255: Sex differences in procedural characteristics and clinical outcomes among patients undergoing bifurcation PCI using second-generation drug-eluting stents

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content